The use of a Vitamin B nutraceutical to treat migraine

Phase 2

Recruiting

• Conditions: Migraine; Neurological - Other neurological disorders; Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12612001195842
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

18 to 65 years of age.
Male or female.
Have a diagnosis of migraine with aura according to International Headache Society Criteria
Participants with adequate venous access in their left and right arms to allow collection of a number of blood samples via venepuncture
Fluent in the English language.
Have voluntarily given written informed consent to participate in this study.

Exclusion Criteria

Other definable cause for clinical presentation (i.e. not migraine).
Other severe illness or use of medication that might interfere with assessment or hamper patients ability to complete the study.
Pregnancy
History of any psychiatric illness which may impair the ability to provide written informed consent.
Poor compliers or those unlikely to attend.
Participation in a clinical trial, or has received any experimental therapy, within the last 30 days.
Donated or lost a significant amount of blood (e.g. 550 mL) within the past 12 weeks.
Persons already taking vitamin B supplementation

Study & Design

• Study Type: Interventional
• Study Design: Not specified